Logo image
Trigeminal injury causes kappa opioid-dependent allodynic, glial and immune cell responses in mice
Journal article   Open access   Peer reviewed

Trigeminal injury causes kappa opioid-dependent allodynic, glial and immune cell responses in mice

Megumi Aita, Margaret R Byers, Charles Chavkin and Mei Xu
Molecular pain, Vol.6(1), pp.8-8
01/29/2010
DOI: 10.1186/1744-8069-6-8
PMCID: PMC2826348
PMID: 20109235
url
https://doi.org/10.1186/1744-8069-6-8View
Published (Version of record) Open Access

Abstract

Background: The dynorphin-kappa opioid receptor (KOR) system regulates glial proliferation after sciatic nerve injury. Here, we investigated its role in cell proliferation following partial ligation of infraorbital nerve (pIONL), a model for trigeminal neuropathic pain. Mechanical allodynia was enhanced in KOR gene deleted mice (KOR-/-) compared to wild type mice. Using bromodeoxyuridine (BrdU) as a mitotic marker, we assessed cell proliferation in three different areas of the trigeminal afferent pathway: trigeminal nucleus principalis (Vp), trigeminal root entry zone (TREZ), and trigeminal ganglion (TG). Results: In KOR-/- mice or norBNI-treated mice, the number of proliferating cells in the Vp was significantly less than in WT mice, whereas cell proliferation was enhanced in TREZ and TG. The majority of the proliferating cells were nestin positive stem cells or CD11b positive microglia in the Vp and macrophages in the TG. GFAP-positive astrocytes made a clear borderline between the CNS and the PNS in TREZ, and phosphorylated KOR staining (KOR-p) was detectable only in the astrocytes in CNS in WT mice but not in KOR-/- or norBNI-treated mice. Conclusions: These results show that kappa opioid receptor system has different effects after pIONL in CNS and PNS: KOR activation promotes CNS astrocytosis and microglial or stem cell proliferation but inhibits macrophage proliferation in PNS. The trigeminal central root has a key role in the etiology and treatment of trigeminal neuralgia, and these newly identified responses may provide new targets for developing pain therapies.
Research

Details

Metrics

Logo image